Evidence map›Paper›PMID 26666460›Full record

ArticleActa physiologica (Oxford, England)2017

Vascular hepoxilin and trioxilins mediate vasorelaxation through TP receptor inhibition in mouse arteries.

L Siangjong, D H Goldman, T Kriska, K M Gauthier, E M Smyth, N Puli, G Kumar, J R Falck, W B Campbell

Open access · greenAbstract read
In one paragraph

Article in Acta physiologica (Oxford, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. RespiratoryFrontiers in immunology · 2018
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

L SiangjongDepartment of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA.
D H GoldmanDepartment of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA.
T KriskaDepartment of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA.
K M GauthierDepartment of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA.
E M SmythDepartment of Pharmacology, University of Pennsylvania, Philadelphia, PA, USA.
N PuliDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX, USA.
G KumarDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX, USA.
J R FalckDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX, USA.
W B CampbellDepartment of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA.
Medical College of Wisconsin · USThe University of Texas Southwestern Medical Center · USSilpakorn University · THUniversity of Pennsylvania · US

Funding

Novel Eicosanoids: Synthesis and FunctionR01GM031278 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI FALCK, JOHN R. · 1985 to 2012
$4.7M
MINORITY BIOMEDICAL RESEARCH SUPPORT PROGRAMR01HL037981 · NHLBI · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI CAMPBELL, WILLIAM BRYSON · 1990 to 2010
$3.7M
Regulation of Vascular Eicosanoid ReceptorsR01HL066233 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI SMYTH, EMER MARIA · 2002 to 2011
$2.9M
Endothelial Lipoxygenase Metabolites and Vascular ToneR01HL103673 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI CAMPBELL, WILLIAM BRYSON · 2011 to 2014
$1.5M
NHLBI NIH HHS R01 HL037981NHLBI NIH HHS R01 HL066233NHLBI NIH HHS R01 HL103673NIGMS NIH HHS R01 GM031278
6 · The paper itself

Abstract

aim12/15-lipoxygenase (12/15-LO) metabolizes arachidonic acid (AA) into several vasoactive eicosanoids. In mouse arteries, we previously characterized the enzyme's 15-LO metabolites 12(S)-hydroxyeicosatetraenoic acid (HETE), 15-HETE, hydroxyepoxyeicosatrienoic acids (HEETAs) and 11,12,15-trihydroxyeicosatrienoic acids (11,12,15-THETAs) as endothelium-derived relaxing factors. However, the observed 12-LO metabolites remained uncharacterized. The purpose of this study was to determine the structure and biological functions of eicosanoids generated by the enzyme's 12-LO activity.

methodsMetabolites extracted from aortas of C57BL/6 male mice were separated using a series of reverse and normal phase chromatographic steps and identified as hepoxilin A

resultsAll identified vascular 12-LO metabolites were biologically active. In mouse mesenteric arteries, trioxilin A

conclusionTrioxilin A

Indexed as

8,11,14-Eicosatrienoic AcidAnimalsAortaHEK293 CellsHumansMaleMesenteric ArteriesMiceMice, Inbred C57BLReceptors, ThromboxaneVasodilationVasodilator Agents8,11,12-trihydroxy-5,9,14-eicosatrienoic acid8,11,14-Eicosatrienoic Acid8-hydroxy-11,12-epoxyeicosa-5,9,14-trienoic acidReceptors, ThromboxaneVasodilator Agentsarachidonic acidendotheliumlipoxygenasesmooth musclethromboxane A2 (TP) receptortrioxilins

Identifiers

PMID26666460
PMCPMC4909587
OpenAlexW2296753542

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.